CN102895454A - Drug for treating pediatric anaphylactoid purpura - Google Patents
Drug for treating pediatric anaphylactoid purpura Download PDFInfo
- Publication number
- CN102895454A CN102895454A CN2012104445077A CN201210444507A CN102895454A CN 102895454 A CN102895454 A CN 102895454A CN 2012104445077 A CN2012104445077 A CN 2012104445077A CN 201210444507 A CN201210444507 A CN 201210444507A CN 102895454 A CN102895454 A CN 102895454A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- drug
- medicament
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a drug for treating pediatric anaphylactoid purpura. The drug is prepared from the following materials in parts by weight: 5-10 parts of fructus kochiae, 1-5 parts of radix glycyrrhizae, 3-10 parts of albizia julibrissin, 5-10 parts of cortex mori, 1-5 parts of flos farfarae, 1-5 parts of rhizoma cyperi, 5-15 parts of Chinese gall, 1-3 parts of semen brassicae, 3-5 parts of herba violae, 1-5 parts of angelica sinensis, 1-5 parts of euphorbia pekinensis, 10-20 parts of rhizoma curculiginis, 15-25 parts of radix semiaquilegiae, 1-20 parts of rhizoma alismatis and 1-20 parts of dandelion. The drug for treating pediatric anaphylactoid purpura is prepared from natural medicinal materials, has an exact curative effect, can effectively treat pediatric anaphylactoid purpura, and thereby being quite suitable for clinical popularization.
Description
Technical field
The present invention relates to children disease prevention and treatment field, relate in particular to a kind of medicament for the treatment of Allergic Purpura in Children.
Background technology
Allergic Purpura in Children (allergic purpura) is a kind of more common blood capillary allergic disease; pathological changes is mainly involved the capillary wall at the positions such as skin, mucosa, gastrointestinal, joint and kidney; its permeability and fragility are increased, so that cause bleeding.At present, the method that needs the new treatment Allergic Purpura in Children of constantly research and development.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of Allergic Purpura in Children.
In order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of Allergic Purpura in Children, it is to be made by the material of following weight proportioning: Fructus Kochiae 5-10 part, Radix Glycyrrhizae 1-5 part, Flos Albiziae 3-10 part, Cortex Mori 5-10 part, Flos Farfarae 1-5 part, Rhizoma Cyperi 1-5 part, Galla Chinensis 5-15 part, Semen Sinapis Albae 1-3 part, Herba Violae 3-5 part, Radix Angelicae Sinensis 1-5 part, Radix Euphorbiae Pekinensis 1-5 part, Rhizoma Curculiginis 10-20 part, Radix Semiaquilegiae 15-25 part, Rhizoma Alismatis 1-20 part and Herba Taraxaci 10-20 part.
Preferably, the medicament for the treatment of Allergic Purpura in Children of the present invention is to be made by the material of following weight proportioning: 15 parts of 6 parts of the Fructus Kochiae, 3 parts in Radix Glycyrrhizae, 5 parts of Flos Albiziaes, 8 parts of Cortex Mori, 2 parts of Flos Farfaraees, 3 parts of Rhizoma Cyperis, 10 parts of Galla Chinensiss, 2 parts of Semen Sinapis Albaes, 4 parts of Herba Violaes, 2 parts of Radix Angelicae Sinensis, 3 parts of Radix Euphorbiae Pekinensiss, 15 parts of Rhizoma Curculiginises, 20 parts of Radix Semiaquilegiaes, 10 parts of Rhizoma Alismatis and Herba Taraxacis.
More preferably, medicament of the present invention is tablet, dispersible tablet, decoction or liniment.
The medicament for the treatment of Allergic Purpura in Children of the present invention all adopts natural drug to make, and curative effect is clear and definite, can effectively treat Allergic Purpura in Children, therefore very suitable clinically popularization.
The specific embodiment
Further specify the present invention below by embodiment.It should be understood that embodiments of the invention are for explanation the present invention rather than limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Except as otherwise noted, otherwise the percent among the present invention is percetage by weight.
The preparation of embodiment 1 decoction
Get the Fructus Kochiae 60 grams, Radix Glycyrrhizae 30 grams, Flos Albiziae 50 grams, Cortex Mori 80 grams, Flos Farfarae 20 grams, Rhizoma Cyperi 30 grams, Galla Chinensis 100 grams, Semen Sinapis Albae 20 grams, Herba Violae 40 grams, Radix Angelicae Sinensis 20 grams, Radix Euphorbiae Pekinensis 30 grams, Rhizoma Curculiginis 150 grams, Radix Semiaquilegiae 200 grams, Rhizoma Alismatis 100 grams and Herba Taraxaci 150 grams, add 4000 ml waters, heating is 2 hours under the condition of 1 normal atmosphere, backflow.Be cooled to room temperature, filter, filtrate is decoction of the present invention.
Experimental example
Totally 36 routine patients, male 24 examples, women 12 examples; The oldest 14 years old, minimum 5 years old.All take the skin purpura as primary symptom, accompany arthralgia, stomachache, hematuria is had blood in stool.All meet the anaphylactoid purpura diagnostic criteria (Xue Xindong. pediatrics [M] .7 version. Beijing: the People's Health Publisher, 2007.196-198.).Get rid of the purple paralysis of idiopathic thrombocytopenic, rheumatic arthritis, infectious disease.
Use the decoction of embodiment 1 preparation to treat, one day twice, each serving with 30 milliliters, treating continuously 10 days was a course for the treatment of.
Efficacy assessment standard
Cure: transference cure, without hematuria, have blood in stool, the purple paralysis of skin, arthralgia.Take a turn for the better: symptom partly disappears.Invalid: symptom is without improvement.
The result
After treatment, 36 patients' skin purpura hour, through checking, arthralgia, stomachache, hematuria, the symptom of having blood in stool also all disappear with arthralgia, stomachache, hematuria, the patient that has blood in stool.This shows that 36 patients all meet criterion of cure.
Untoward reaction
In therapeutic process, carry out tracing observation for 36 routine patients, do not find obvious untoward reaction.
Claims (3)
1. medicament for the treatment of Allergic Purpura in Children, it is characterized in that it is to be made by the material of following weight proportioning: Fructus Kochiae 5-10 part, Radix Glycyrrhizae 1-5 part, Flos Albiziae 3-10 part, Cortex Mori 5-10 part, Flos Farfarae 1-5 part, Rhizoma Cyperi 1-5 part, Galla Chinensis 5-15 part, Semen Sinapis Albae 1-3 part, Herba Violae 3-5 part, Radix Angelicae Sinensis 1-5 part, Radix Euphorbiae Pekinensis 1-5 part, Rhizoma Curculiginis 10-20 part, Radix Semiaquilegiae 15-25 part, Rhizoma Alismatis 1-20 part and Herba Taraxaci 10-20 part.
2. the medicament for the treatment of Allergic Purpura in Children according to claim 1, it is characterized in that it is to be made by the material of following weight proportioning: 15 parts of 6 parts of the Fructus Kochiae, 3 parts in Radix Glycyrrhizae, 5 parts of Flos Albiziaes, 8 parts of Cortex Mori, 2 parts of Flos Farfaraees, 3 parts of Rhizoma Cyperis, 10 parts of Galla Chinensiss, 2 parts of Semen Sinapis Albaes, 4 parts of Herba Violaes, 2 parts of Radix Angelicae Sinensis, 3 parts of Radix Euphorbiae Pekinensiss, 15 parts of Rhizoma Curculiginises, 20 parts of Radix Semiaquilegiaes, 10 parts of Rhizoma Alismatis and Herba Taraxacis.
3. the medicament for the treatment of Allergic Purpura in Children according to claim 1 and 2 is characterized in that, described medicament is tablet, dispersible tablet, decoction or liniment.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012104445077A CN102895454B (en) | 2012-11-09 | 2012-11-09 | Drug for treating pediatric anaphylactoid purpura |
CN201310463840.7A CN103566121B (en) | 2012-11-09 | 2012-11-09 | A kind of preparation method for the treatment of the medicament of Allergic Purpura in Children |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2012104445077A CN102895454B (en) | 2012-11-09 | 2012-11-09 | Drug for treating pediatric anaphylactoid purpura |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310463840.7A Division CN103566121B (en) | 2012-11-09 | 2012-11-09 | A kind of preparation method for the treatment of the medicament of Allergic Purpura in Children |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102895454A true CN102895454A (en) | 2013-01-30 |
CN102895454B CN102895454B (en) | 2013-11-13 |
Family
ID=47568140
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310463840.7A Expired - Fee Related CN103566121B (en) | 2012-11-09 | 2012-11-09 | A kind of preparation method for the treatment of the medicament of Allergic Purpura in Children |
CN2012104445077A Expired - Fee Related CN102895454B (en) | 2012-11-09 | 2012-11-09 | Drug for treating pediatric anaphylactoid purpura |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310463840.7A Expired - Fee Related CN103566121B (en) | 2012-11-09 | 2012-11-09 | A kind of preparation method for the treatment of the medicament of Allergic Purpura in Children |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN103566121B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103071028A (en) * | 2013-03-01 | 2013-05-01 | 宋艳霞 | Traditional Chinese medicinal composition for treating anaphylactoid purpura |
CN107019751A (en) * | 2017-05-26 | 2017-08-08 | 王滋东 | Treat the medicine of Allergic Purpura in Children |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101019983A (en) * | 2007-03-19 | 2007-08-22 | 殷彬 | Chinese medicine for treating allergic purpura |
-
2012
- 2012-11-09 CN CN201310463840.7A patent/CN103566121B/en not_active Expired - Fee Related
- 2012-11-09 CN CN2012104445077A patent/CN102895454B/en not_active Expired - Fee Related
Non-Patent Citations (3)
Title |
---|
李艳英,等: "过敏性紫癜中医辨证论治的体会", 《贵阳中医学院学报》 * |
舒萍,等: "儿童过敏性紫癜的中医治疗进展", 《中国医药指南》 * |
陈云健: "过敏性紫癜的中医治疗进展", 《亚太传统医药》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103071028A (en) * | 2013-03-01 | 2013-05-01 | 宋艳霞 | Traditional Chinese medicinal composition for treating anaphylactoid purpura |
CN107019751A (en) * | 2017-05-26 | 2017-08-08 | 王滋东 | Treat the medicine of Allergic Purpura in Children |
Also Published As
Publication number | Publication date |
---|---|
CN103566121B (en) | 2015-11-11 |
CN103566121A (en) | 2014-02-12 |
CN102895454B (en) | 2013-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101690745B (en) | Chinese medicinal composition for preventing and treating flu | |
CN102309699A (en) | Traditional Chinese medicine (TCM) prescription for treating cervical cellulitis | |
CN103394070A (en) | Chinese medicine preparation for treating influenza | |
CN103585413A (en) | Medicine for external application for treating traumatic injuries | |
CN102178864A (en) | Chinese medicinal oral liquid for treating amygdalitis | |
CN102430071B (en) | Medicament for treating herpes zoster | |
CN102895454B (en) | Drug for treating pediatric anaphylactoid purpura | |
CN103385980A (en) | Decoction for treating pneumonia | |
CN102139051B (en) | Application of soft capsule capable of clearing heat and eliminating toxin in preparation of medicament for treating viral pneumonia | |
CN104524178A (en) | Traditional Chinese medicine composition for treating facial paralysis | |
CN102416098B (en) | Medicine preparation used for treating upper respiratory tract infection | |
CN103041182B (en) | Traditional Chinese medicine preparation for curing neurasthenia | |
CN103272186B (en) | Traditional Chinese medicine for curing curettage amenorrhea | |
CN103520558A (en) | Method for preparing medicine composition used for treating children suppurative tonsillitis | |
CN103505593B (en) | Chinese medicinal herb formula for removing necrotic tissue and promoting tissue regeneration | |
CN102988841A (en) | Chinese medicament for treating cutaneous pruritus | |
CN102526373B (en) | Medicinal composition for treating infantile anorexia | |
CN102908566B (en) | Medicament for treating interstitial pneumonia | |
CN105616516A (en) | Epidemic cerebrospinal meningitis treating injection and preparation method thereof | |
CN104800385A (en) | Traditional Chinese medicine for treating recurrent erysipelas | |
CN102671048B (en) | Medicament for treating chronic urinary tract infections | |
CN103041346A (en) | Decoction for treating dysmenorrhea | |
CN103623112A (en) | Traditional Chinese medicine composition for treating cutaneous pruritus and preparation method | |
CN104825838B (en) | A kind of medicine for the treatment of acute upper respiratory tract infection | |
CN103550516A (en) | Preparation method of medicament for treating perianal abscess |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131113 Termination date: 20141109 |
|
EXPY | Termination of patent right or utility model |